Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services
Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.






